FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of ($0.19), in-line with the analyst estimate of ($0.19).
We continue our strong momentum across our operations throughout early 2020, said Rosty Raykov, chief executive officer of Fennec Pharmaceuticals. "Following the recent announcement of regulatory submission... More

